These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 3469440)
21. [Prevalence of HIV antigens in cerebrospinal fluid and in serum of patients with both asymptomatic and symptomatic HIV infection]. Radkowski M; Laskus T; Kopicz-Kamińska E; Mian M; Babiuch L; Slusarczyk J Pol Tyg Lek; 1992 Sep 7-14; 47(36-37):784-6. PubMed ID: 1293560 [TBL] [Abstract][Full Text] [Related]
22. Secretory IgA antibodies to human immunodeficiency virus in the parotid saliva of patients with AIDS and AIDS-related complex. Archibald DW; Barr CE; Torosian JP; McLane MF; Essex M J Infect Dis; 1987 Apr; 155(4):793-6. PubMed ID: 3469280 [No Abstract] [Full Text] [Related]
23. AIDS: a review and guide for infection control. Den Beste BP; Hummer J J Am Optom Assoc; 1986 Sep; 57(9):675-82. PubMed ID: 3639901 [TBL] [Abstract][Full Text] [Related]
24. [Antibodies to the structural and nonstructural gag-coded proteins of type-D retroviruses in patients with lymphadenopathy]. Morozov VA; Il'inskiĭ PO; Il'in KV Biull Eksp Biol Med; 1988 Dec; 106(12):706-8. PubMed ID: 3264729 [TBL] [Abstract][Full Text] [Related]
25. Neutralizing antibodies and serum interferon levels in the different stages of HIV infection. Szabó B; Tóth FD; Kiss J; Ujhelyi E; Füst G; Horváth A; Hollán SR Acta Virol; 1990 Apr; 34(2):164-70. PubMed ID: 1975977 [TBL] [Abstract][Full Text] [Related]
26. Decreased population of Leu-7+ natural killer cells in lymph nodes of homosexual men with AIDS-related persistent lymphadenopathy. Jothy S; Gilmore N; El'Gabalawy H; Prchal J Can Med Assoc J; 1985 Jan; 132(2):141-4. PubMed ID: 3965066 [TBL] [Abstract][Full Text] [Related]
27. [Affinity of anti-HIV antibodies in patients with asymptomatic and symptomatic HIV infection]. Radkowski M; Laskus T; Goch A; Babiuch L; Slusarczyk J Przegl Epidemiol; 1991; 45(4):369-72. PubMed ID: 1841418 [TBL] [Abstract][Full Text] [Related]
28. [Acquired immunodeficiency syndrome and generalized lymphadenopathy in persons seropositive for the HIV virus]. Pokrovskiĭ VV; Iankina ZK; Pokrovskiĭ VI; Potekaev NS; Etkin AF Ter Arkh; 1987; 59(7):35-9. PubMed ID: 3499677 [TBL] [Abstract][Full Text] [Related]
29. Human immunodeficiency virus antigenemia in patients with AIDS and AIDS-related disorders: a comparison between European and Central African populations. Baillou A; Barin F; Allain JP; Petat E; Kocheleff P; Kadende P; Goudeau A J Infect Dis; 1987 Nov; 156(5):830-3. PubMed ID: 3477600 [No Abstract] [Full Text] [Related]
30. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS). Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767 [TBL] [Abstract][Full Text] [Related]
31. Antibody to human lymphotropic virus type III: immunologic status of homosexual contacts of patients with the acquired immunodeficiency syndrome and the acquired immunodeficiency-related complex. Goldsmith JM; Kalish SB; Ostrow DG; Britz J; Chmiel JS; Wallemark CB; Phair JP Sex Transm Dis; 1987; 14(1):44-7. PubMed ID: 2951878 [TBL] [Abstract][Full Text] [Related]
32. Monoclonal antibodies to human immunodeficiency virus: their relation to the patterns of lymph node changes in persistent generalized lymphadenopathy and AIDS. Tenner-Rácz K; Rácz P; Dietrich M; Kern P; Janossy G; Veronese-Dimarzo F; Klatzmann D; Gluckman JC; Popovic M AIDS; 1987 Jul; 1(2):95-104. PubMed ID: 3130085 [TBL] [Abstract][Full Text] [Related]
33. [Prevalence of antibodies against HTLV-III in the at risk population in Madrid. Clinical study and incidence of virologic markers]. González Lahoz JM; Gutiérrez Angulo MT; Polo Rodríguez R; Subirats Núñez M; Moreno Celda V; Baquero Mochales M Rev Clin Esp; 1987 May; 180(8):416-9. PubMed ID: 3649830 [No Abstract] [Full Text] [Related]
34. [HIV-correlated antigens and antibodies in patients treated with zidovudine]. Garavelli PL; Dallavalle FM Minerva Med; 1990; 81(7-8 Suppl):93-4. PubMed ID: 2216047 [TBL] [Abstract][Full Text] [Related]
35. Prevalence of HTLV III/LAV and other viral antibodies in normal and at risk populations. Ferrante P; Nardi G; Zanchetta N; Salvioni PM; Pagano A Boll Ist Sieroter Milan; 1986; 65(5):357-60. PubMed ID: 3030363 [TBL] [Abstract][Full Text] [Related]
36. [Diagnosis of AIDS in postmortem conditions]. Püschel K; Lieske K; Janssen W; Racz P; Karch H; Laufs R Beitr Gerichtl Med; 1987; 45():129-34. PubMed ID: 3478043 [No Abstract] [Full Text] [Related]
37. Early warning skin signs in AIDS and persistent generalized lymphadenopathy. Muhlemann MF; Anderson MG; Paradinas FJ; Key PR; Dawson SG; Evans BA; Murray-Lyon IM; Cream JJ Br J Dermatol; 1986 Apr; 114(4):419-24. PubMed ID: 3008802 [TBL] [Abstract][Full Text] [Related]
38. [Retroviral infections by HIV-1, HIV-2 and AIDS-related complex in the Ivory Coast]. Ouattara A; Rey MA; Brun-Vésinet F; Kindbeiter K; de Thé G C R Acad Sci III; 1988; 306(2):47-50. PubMed ID: 2894887 [TBL] [Abstract][Full Text] [Related]
39. HIV antigen testing. Kenny C; Parkin J; Underhill G; Shah N; Burnell B; Osborne E; Jeffries DJ Lancet; 1987 Mar; 1(8532):565-6. PubMed ID: 2881114 [No Abstract] [Full Text] [Related]
40. Use of a sensitive neutralization assay to measure the prevalence of antibodies to the human immunodeficiency virus. Vujcic LK; Shepp DH; Klutch M; Wells MA; Hendry RM; Wittek AE; Krilov L; Quinnan GV J Infect Dis; 1988 May; 157(5):1047-50. PubMed ID: 3162928 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]